"Long-term antibiotic treatment designed to fight a common but stubborn bacterial infection does not reduce the risk of heart attack, according to two studies released on Wednesday.
Previous studies found that more than three-quarters of heart attack patients were infected with Chlamydia pneumonia, a bug present in the fatty plaques that clog arteries"
It blows my mind that none of these studies use a regimen which includes pulsed Metronidazole. Why not I wonder?
CONCLUSION: The combination of doxycycline and rifampin for 9 months seemed to be effective in treatment of chronic uSpA. This is the first study to demonstrate therapeutic benefit with antimicrobials to a chronic inflammatory arthritis possibly secondary to persistent Chlamydia.
Users browsing this forum: No registered users